角膜移植の世界市場

角膜移植の世界市場は2030年までに5億7,710万米ドルに達する見込み

2024年に4億5,520万米ドルと推定される角膜移植の世界市場は、2030年には5億7,710万米ドルに達し、分析期間2024-2030年のCAGRは4.0%で成長すると予測されます。本レポートで分析したセグメントの1つである浸透角膜形成術は、CAGR 5.7％を記録し、分析期間終了時には1億8,030万米ドルに達すると予測されています。内皮角膜形成術セグメントの成長率は、分析期間中CAGR 2.6％と推定されます。

米国市場は1億2,400万米ドルと推定、中国はCAGR7.7％で成長予測

米国の角膜移植市場は、2024年に1億2,400万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを7.7%として、2030年までに1億1,930万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.5%と3.2%と予測されています。欧州では、ドイツがCAGR 2.3%で成長すると予測されています。

世界の角膜移植市場- 主要動向と促進要因のまとめ

角膜移植が世界的に臨床・調査の機運を再び高めている理由とは？

角膜移植は、角膜混濁、ジストロフィー、変性または感染性の角膜症に罹患した患者に視力の回復を提供し、世界中で最も成功し、一般的に行われている臓器移植術の1つです。高齢化、外傷、感染症などが原因で角膜失明の世界の有病率が増加するにつれ、効果的で利用しやすく、再現性の高い角膜移植術に対する需要は着実に高まっています。多くの患者、特に低所得者や十分な治療を受けていない地域の患者にとって、角膜移植は生涯にわたる視覚障害や失明を避けるための唯一の治療法です。

手術技術、組織保存技術、ドナーのスクリーニング・プロトコルの進歩は、角膜移植の安全性と有効性を再定義しています。全層貫通型角膜移植術（PK）から、デスメ膜剥離自動内皮角膜移植術（DSAEK）やデスメ膜内皮角膜移植術（DMEK）のような選択的ラメラ移植術へと臨床的嗜好がシフトしていることは、治療成績と回復時間を向上させています。このような手術の移行は、特に世界中の卓越した眼科センターにおける、診断、手術機器、および外科医トレーニングインフラの改善によって支えられています。

角膜移植の将来を形作る技術的・臨床的進歩とは？

ドナー組織の取り扱いと手術精度の両方において、大きな技術革新が進行中です。アイバンクは、術中のばらつきを減らし、移植の一貫性を向上させるために、プレカットやプレストリッピング移植片のような高度な組織準備技術を採用しています。低体温および臓器培養保存法は、ドナー組織の長期保存と国際輸送を可能にし、入手可能性の地理的格差を埋めるのに役立っています。

フェムトセカンド・レーザー支援角膜移植術は、超精密なトレフィネーションと無縫合創の構築を可能にすることで、移植片界面の品質に革命をもたらしています。一方、術中OCT（光干渉断層計）は、特に内皮手術において、移植片とホストのアライメントや液体の界面をリアルタイムで可視化するために、ますます使用されるようになってきています。組織接着剤、マイクロインジェクション送達ツール、より侵襲の少ない切開手技は、術後の回復をさらに早め、合併症を最小限に抑えています。

新しいフロンティアとしては、合成角膜インプラント、生体工学的足場、異種移植片の使用があり、これらはヒトのドナー組織が入手できない、あるいは不適当な患者に対して試用されています。研究者たちはまた、内皮機能不全に対する培養内皮細胞注入などの細胞ベースの治療法の役割も模索しており、完全な移植片の必要性を完全に排除できる可能性があります。人工知能は、ドナーとレシピエントのマッチング・アルゴリズム、術後のモニタリング、複数のパラメトリック入力に基づく移植片の生存予測などに活用されています。

主な利害関係者は誰か、また地理的動向は採用にどのような影響を与えているか？

角膜移植エコシステムの主要利害関係者には、眼科外科医、アイバンク、病院ベースの移植プログラム、非営利の眼科医療財団、全国臓器提供ネットワークなどが含まれます。米国、ドイツ、日本、オーストラリアなどの新興国市場では、ドナー角膜へのアクセスは十分に規制されており、強固な償還制度と集中化されたアイバンクサービスによって支えられています。これらの国々では、より良好な視力回復、低い拒絶反応率、手術外傷の軽減を提供する内皮角膜移植術への急速な移行が見られます。

対照的に、アジア、アフリカ、ラテンアメリカの新興国は、ドナー不足、未発達のアイバンキング・インフラ、限られた手術能力に関する課題に直面しています。インドは角膜失明の負担が大きいにもかかわらず、全国的な献眼キャンペーンや官民連携モデルによる地域アイバンクの拡大を通じて前進を遂げました。サハラ以南のアフリカや東南アジアの国々も、移植候補者のタイムリーな特定と紹介を促進するために、遠隔眼科や移動式角膜スクリーニング装置を採用しています。

WHO、オルビスインターナショナル、および各国の省庁が主導する国際的な眼科医療イニシアチブは、十分なサービスを受けていない地域における認識、トレーニング、および資源配分の改善に取り組んでいます。さらに、学術センターと移植学会の世界の協力関係により、技能開発、標準化、国境を越えた技術革新の普及を促進する知識共有プラットフォームが構築されつつあります。

角膜移植市場の成長加速の原動力は？

角膜移植市場の成長は、医療ニーズ、技術的成熟度、ドナー組織ロジスティクスのシステム改善の組み合わせによってもたらされます。円錐角膜、フックス内皮ジストロフィー、外傷による角膜損傷の増加により、一貫した手術需要が生じています。同時に、選択的ラメラ移植術の成功により、合併症の発生率が低下し、より幅広い患者層が手術を受けられるようになっています。

組織の安全性試験や保存ガイドラインの標準化など、規制の枠組みが改善されたことで、国際的な組織共有のエコシステムが拡大しています。特に新興国市場においては、償還政策が先進的な外科手術の選択肢や技術の採用を後押ししています。これと並行して、世界の医療機関は、外科医を養成し、外科的アウトリーチを拡大し、献眼パイプラインを強化するための能力開発プログラムに投資しています。

合成角膜や生物工学的角膜代替物の技術革新は、特に持続的な不足に直面している地域において、ドナー依存を克服する長期的な可能性を提供します。個別化医療と再生療法が進展するにつれ、市場セグメンテーションは単発的な手術分野から、世界の眼科医療における統合された技術主導の分野へと進化しつつあり、その持続的成長と治療効果の拡大を確実なものにしています。

セグメント

処置タイプ（貫通角膜移植術、内皮角膜移植術、デスメット剥離自動内皮角膜移植術、角膜移植、角膜辺縁幹細胞移植、その他の処置）;適応症（真菌性角膜潰瘍、水疱性角膜症、円錐角膜、角膜炎、その他の適応症）;エンドユーザー（病院、眼科クリニック、その他のエンドユーザー）

調査対象企業の例（注目の44社）

• AJL Ophthalmic SA
• Alcon, Inc.
• Aurolab
• CorneaGen
• CorNeat Vision Ltd.
• CryoLife, Inc.
• DIOPTEX GmbH
• ExaTech, Inc.
• EyeYon Medical Ltd.
• Florida Lions Eye Bank
• KeraMed, Inc.
• Kohler GmbH
• LifeCell
• Lifeline Scientific Inc.
• LinkoCare Life Sciences AB
• Massachusetts Eye and Ear
• Medtronic
• Presbia PLC
• San Diego Eye Bank

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

無料アップデート弊社のお客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Corneal Transplants Market to Reach US$577.1 Million by 2030

The global market for Corneal Transplants estimated at US$455.2 Million in the year 2024, is expected to reach US$577.1 Million by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Penetrating Keratoplasty Procedure, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$180.3 Million by the end of the analysis period. Growth in the Endothelial Keratoplasty Procedure segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$124.0 Million While China is Forecast to Grow at 7.7% CAGR

The Corneal Transplants market in the U.S. is estimated at US$124.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$119.3 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Corneal Transplants Market - Key Trends & Drivers Summarized

Why Are Corneal Transplants Gaining Renewed Clinical and Research Momentum Globally?

Corneal transplants remain one of the most successful and commonly performed organ transplant procedures worldwide, offering restorative vision to patients affected by corneal opacities, dystrophies, and degenerative or infectious keratopathies. As global prevalence of corneal blindness increases-driven by aging populations, trauma, and infectious diseases-the demand for effective, accessible, and repeatable corneal grafting procedures is steadily growing. For many patients, especially in lower-income or underserved regions, corneal transplantation represents the only curative solution to avoid lifelong visual impairment or blindness.

Advancements in surgical techniques, tissue preservation technologies, and donor screening protocols are redefining the safety and efficacy of corneal transplants. Shifting clinical preferences from full-thickness penetrating keratoplasty (PK) toward selective lamellar procedures-such as Descemet stripping automated endothelial keratoplasty (DSAEK) and Descemet membrane endothelial keratoplasty (DMEK)-are improving outcomes and recovery times. This surgical transition is supported by improved diagnostics, surgical instrumentation, and surgeon training infrastructure, particularly in ophthalmology centers of excellence across the globe.

What Technological and Clinical Advancements Are Shaping the Future of Corneal Grafting?

Significant innovation is underway in both donor tissue handling and surgical precision. Eye banks are adopting advanced tissue preparation techniques-such as pre-cut and pre-stripped grafts-that reduce intraoperative variability and improve transplant consistency. Hypothermic and organ culture preservation methods are enabling longer storage and international shipment of donor tissue, helping to bridge geographic disparities in availability.

Femtosecond laser-assisted keratoplasty is revolutionizing graft interface quality by enabling ultra-precise trephination and sutureless wound construction. Meanwhile, intraoperative OCT (optical coherence tomography) is being increasingly used for real-time visualization of graft-host alignment and fluid interface, especially in endothelial procedures. Tissue adhesives, micro-injection delivery tools, and less invasive incision techniques are further accelerating postoperative recovery and minimizing complications.

Emerging frontiers include the use of synthetic corneal implants, bioengineered scaffolds, and xenografts, which are being trialed in patients for whom human donor tissue is unavailable or unsuitable. Researchers are also exploring the role of cell-based therapies-such as cultured endothelial cell injections-for endothelial dysfunctions, potentially eliminating the need for full grafts altogether. Artificial intelligence is being leveraged for donor-recipient matching algorithms, postoperative monitoring, and predicting graft survival based on multi-parametric inputs.

Who Are the Major Stakeholders and How Are Geographic Trends Influencing Adoption?

The key stakeholders in the corneal transplant ecosystem include ophthalmic surgeons, eye banks, hospital-based transplant programs, non-profit eye health foundations, and national organ donation networks. In developed markets such as the U.S., Germany, Japan, and Australia, access to donor corneas is well-regulated and supported by robust reimbursement systems and centralized eye banking services. These countries are witnessing a rapid shift toward endothelial keratoplasty techniques that offer better visual recovery, lower rejection rates, and reduced surgical trauma.

In contrast, emerging economies in Asia, Africa, and Latin America face challenges related to donor scarcity, underdeveloped eye banking infrastructure, and limited surgical capacity. India, despite a high burden of corneal blindness, has made strides through national eye donation campaigns and the expansion of regional eye banks under public-private partnership models. Countries in Sub-Saharan Africa and Southeast Asia are also adopting teleophthalmology and mobile corneal screening units to facilitate timely identification and referral of transplant candidates.

International eye health initiatives-spearheaded by WHO, Orbis International, and national ministries-are working to improve awareness, training, and resource allocation in underserved regions. Additionally, global collaborations between academic centers and transplant societies are creating knowledge-sharing platforms that drive skill development, standardization, and innovation diffusion across borders.

What Is Driving the Accelerated Growth in the Corneal Transplants Market?

The growth in the corneal transplants market is driven by a combination of medical need, technological maturity, and systemic improvements in donor tissue logistics. Rising incidence of keratoconus, Fuchs endothelial dystrophy, and trauma-related corneal damage is generating consistent procedural demand. At the same time, the success of selective lamellar grafting techniques is reducing complication rates and making surgery accessible to broader patient cohorts.

Improved regulatory frameworks, such as the standardization of tissue safety testing and preservation guidelines, are expanding the international tissue-sharing ecosystem. Reimbursement policies, especially in developed markets, are supporting the adoption of advanced surgical options and technologies. In parallel, global health organizations are investing in capacity-building programs to train surgeons, expand surgical outreach, and enhance the eye donation pipeline.

Innovation in synthetic and bioengineered corneal substitutes offers long-term potential to overcome donor dependency, particularly in regions facing persistent shortages. As personalized medicine and regenerative therapies progress, the corneal transplants market is evolving from an episodic surgical discipline into an integrated, technology-driven segment of global ophthalmic care-ensuring its sustained growth and expanding therapeutic impact.

SCOPE OF STUDY:

The report analyzes the Corneal Transplants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Procedure Type (Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants, Other Procedures); Indication (Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis, Other Indications); End-Use (Hospitals, Eye Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• AJL Ophthalmic SA
• Alcon, Inc.
• Aurolab
• CorneaGen
• CorNeat Vision Ltd.
• CryoLife, Inc.
• DIOPTEX GmbH
• ExaTech, Inc.
• EyeYon Medical Ltd.
• Florida Lions Eye Bank
• KeraMed, Inc.
• Kohler GmbH
• LifeCell
• Lifeline Scientific Inc.
• LinkoCare Life Sciences AB
• Massachusetts Eye and Ear
• Medtronic
• Presbia PLC
• San Diego Eye Bank

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Corneal Transplants - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Corneal Blindness and Degenerative Eye Conditions Drives Demand for Corneal Transplants
  • Expansion of Eye Banking and Donor Tissue Availability Throws the Spotlight on Surgical Accessibility
  • Growth in Femtosecond Laser and Lamellar Keratoplasty Techniques Enhances Transplant Precision
  • OEM Innovation in DMEK and DSAEK Surgical Tools Strengthens Minimally Invasive Transplant Outcomes
  • Increased Success Rates and Visual Recovery Accelerate Surgeon and Patient Acceptance
  • Surge in Aging Population and Diabetes-Related Eye Disorders Supports Global Market Expansion
  • Focus on Artificial Corneas and Bioengineered Grafts Drives Research in Synthetic Alternatives
  • Regulatory Approvals of Eye Tissue Preservation and Transport Solutions Enhance Logistics
  • OEM Investment in Custom-Fit and Preloaded Graft Kits Improves Surgical Workflow and Efficiency
  • Growth in Global Outreach and Mission-Based Eye Surgeries Expands Access in Low-Income Regions
  • OEM Partnerships With Eye Banks and NGOs Support Tissue Donation Infrastructure
  • Adoption of Corneal Cross-Linking in Early-Stage Keratoconus Delays Need for Full-Thickness Transplants
  • OEM Development of Training Simulators and Virtual Surgery Tools Enhances Surgeon Skills
  • Expansion of Private Eye Care Centers in Emerging Markets Supports Elective Procedure Growth
  • Integration of Tele-Ophthalmology in Referral Networks Streamlines Patient Evaluation for Transplant
  • OEM Focus on Low-Rejection Tissue Typing and Immunosuppression Protocols Improves Graft Longevity
  • Use of AI in Pre-Surgical Mapping and Post-Transplant Monitoring Enhances Clinical Decision-Making
  • Global Efforts to Reduce Transplant Waiting Lists Sustain Policy-Level Support
  • Focus on Bilateral Disease Treatment and Cosmetic Restoration Expands Surgical Demand Beyond Function
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Corneal Transplants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Corneal Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Corneal Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Corneal Transplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Penetrating Keratoplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Penetrating Keratoplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Penetrating Keratoplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Endothelial Keratoplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Endothelial Keratoplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Endothelial Keratoplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Descemet Stripping Automated Endothelial Keratoplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Descemet Stripping Automated Endothelial Keratoplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Descemet Stripping Automated Endothelial Keratoplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Corneal Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Corneal Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Corneal Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Corneal Limbal Stem Cell Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Corneal Limbal Stem Cell Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Corneal Limbal Stem Cell Transplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Keratitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Keratitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Keratitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Fungal Corneal Ulcer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Fungal Corneal Ulcer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Fungal Corneal Ulcer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Bullous Keratopathy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Bullous Keratopathy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Bullous Keratopathy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Keratoconus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Keratoconus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Keratoconus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Eye Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Eye Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Eye Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Corneal Transplants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Corneal Transplants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Corneal Transplants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Corneal Transplants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Corneal Transplants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Corneal Transplants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Corneal Transplants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Corneal Transplants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Corneal Transplants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Corneal Transplants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Corneal Transplants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Corneal Transplants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Corneal Transplants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Corneal Transplants by Procedure Type - Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Corneal Transplants by Procedure Type - Percentage Breakdown of Value Sales for Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Grafts, Corneal Limbal Stem Cell Transplants and Other Procedures for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Corneal Transplants by Indication - Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Corneal Transplants by Indication - Percentage Breakdown of Value Sales for Keratitis, Other Indications, Fungal Corneal Ulcer, Bullous Keratopathy and Keratoconus for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Corneal Transplants by End-Use - Hospitals, Eye Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Corneal Transplants by End-Use - Percentage Breakdown of Value Sales for Hospitals, Eye Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION